Indeed, several studies reported that the addition of IL-21 or IL-15 results in increased proportion of CAR-TSCM and TCM (including WT1- and CD19-CAR-T cells) associated with enhanced persistence and anti-tumor effects (85, 136–140). This evidence concerns the gene CD19 and neoplasm.